hVIVO (HVO) Competitors GBX 8.15 -0.15 (-1.81%) As of 08:36 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesBuy This Stock HVO vs. PRTC, VRP, FARN, AVCT, ARIX, CIR, BVXP, 4BB, TILS, and VSNShould you be buying hVIVO stock or one of its competitors? The main competitors of hVIVO include PureTech Health (PRTC), Verona Pharma plc (VRP.L) (VRP), Faron Pharmaceuticals Oy (FARN), Avacta Group (AVCT), Arix Bioscience (ARIX), Circassia Group (CIR), Bioventix (BVXP), 4basebio (4BB), Tiziana Life Sciences (TILS), and Verseon (VSN). These companies are all part of the "biotechnology" industry. hVIVO vs. Its Competitors PureTech Health Verona Pharma plc (VRP.L) Faron Pharmaceuticals Oy Avacta Group Arix Bioscience Circassia Group Bioventix 4basebio Tiziana Life Sciences Verseon hVIVO (LON:HVO) and PureTech Health (LON:PRTC) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, institutional ownership, dividends, risk, earnings, media sentiment, analyst recommendations and profitability. Is HVO or PRTC more profitable? hVIVO has a net margin of 25.96% compared to PureTech Health's net margin of -17,620.94%. hVIVO's return on equity of 47.93% beat PureTech Health's return on equity.Company Net Margins Return on Equity Return on Assets hVIVO25.96% 47.93% 11.97% PureTech Health -17,620.94%-21.15%-13.39% Does the media prefer HVO or PRTC? In the previous week, PureTech Health had 32 more articles in the media than hVIVO. MarketBeat recorded 40 mentions for PureTech Health and 8 mentions for hVIVO. hVIVO's average media sentiment score of 0.91 beat PureTech Health's score of 0.29 indicating that hVIVO is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment hVIVO 1 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PureTech Health 8 Very Positive mention(s) 6 Positive mention(s) 23 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts prefer HVO or PRTC? hVIVO presently has a consensus price target of GBX 23, suggesting a potential upside of 182.21%. PureTech Health has a consensus price target of GBX 455, suggesting a potential upside of 255.85%. Given PureTech Health's higher possible upside, analysts plainly believe PureTech Health is more favorable than hVIVO.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score hVIVO 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00PureTech Health 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders & institutionals believe in HVO or PRTC? 4.6% of hVIVO shares are held by institutional investors. Comparatively, 53.1% of PureTech Health shares are held by institutional investors. 4.4% of hVIVO shares are held by insiders. Comparatively, 13.1% of PureTech Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has preferable earnings & valuation, HVO or PRTC? hVIVO has higher revenue and earnings than PureTech Health. hVIVO is trading at a lower price-to-earnings ratio than PureTech Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatiohVIVO£62.73M0.89£17.84M£0.02525.81PureTech Health£6.17M50.12-£91.86M£0.17752.14 Which has more volatility and risk, HVO or PRTC? hVIVO has a beta of 0.97, indicating that its stock price is 3% less volatile than the S&P 500. Comparatively, PureTech Health has a beta of 1.02, indicating that its stock price is 2% more volatile than the S&P 500. SummaryPureTech Health beats hVIVO on 8 of the 15 factors compared between the two stocks. Get hVIVO News Delivered to You Automatically Sign up to receive the latest news and ratings for HVO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HVO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HVO vs. The Competition Export to ExcelMetrichVIVOBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£56.01M£231.09M£5.76B£2.58BDividend Yield2.02%3.78%5.53%5.33%P/E Ratio525.8131.9076.255,422.61Price / Sales0.894,690.26470.4997,659.15Price / Cash4.9413.1937.4627.93Price / Book1.47127.1813.358.86Net Income£17.84M-£90.99M£3.29B£5.89B7 Day Performance-16.42%-0.06%1.83%0.96%1 Month Performance-18.50%18.23%3.98%2.92%1 Year Performance-72.61%680.37%74.39%177.77% hVIVO Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HVOhVIVO2.1873 of 5 starsGBX 8.15-1.8%GBX 23+182.2%-70.8%£56.01M£62.73M525.81N/ANews CoverageEarnings ReportAnalyst ForecastPRTCPureTech Health2.2239 of 5 starsGBX 107.20-1.1%GBX 455+324.4%-11.7%£259.09M£6.17M630.59300Insider TradeHigh Trading VolumeVRPVerona Pharma plc (VRP.L)N/AN/AN/AN/A£228MN/A-1.6822Gap UpFARNFaron Pharmaceuticals OyN/AGBX 187.90+0.2%N/A-8.4%£210.36MN/A-695.9334Gap DownAVCTAvacta GroupN/AGBX 52.35-0.3%N/A-8.8%£210.33M£113K-341.26120ARIXArix BioscienceN/AN/AN/AN/A£183.73M£14.16M1,290.919CIRCircassia GroupN/AN/AN/AN/A£142.66M£27.90M3,400.00111Gap DownBVXPBioventixN/AGBX 2,466.50+0.7%N/A-37.9%£128.88M£13.66M1,665.2012News CoverageHigh Trading Volume4BB4basebio1.2908 of 5 starsGBX 831-1.1%GBX 1,600+92.5%-46.4%£128.68M£933K-884.04101TILSTiziana Life SciencesN/AN/AN/AN/A£113.85M-£3.60M-3.5911News CoverageVSNVerseonN/AN/AN/AN/A£112.24MN/A-5.17N/AGap Up Related Companies and Tools Related Companies PRTC Competitors VRP Competitors FARN Competitors AVCT Competitors ARIX Competitors CIR Competitors BVXP Competitors 4BB Competitors TILS Competitors VSN Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:HVO) was last updated on 9/24/2025 by MarketBeat.com Staff From Our PartnersWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredRefund From 1933: Trump’s Reset May Create Instant WealthTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredRecession Risk: 90% — Are Your Savings Ready?Moody's latest report shows one-third of U.S. economic activity is already in recession or at high risk.Lear Capital | SponsoredWall Street laughed at Trump’s “Smart Dollar.” Now they’re all in."THIS is the Biggest Economic Story of 2025" While most Americans are focused on tariffs and inflation, the...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding hVIVO plc Please log in to your account or sign up in order to add this asset to your watchlist. Share hVIVO With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HVO Stock Alerts